Viking Therapeutics Inc
VKTX
Equity
ISIN US92686J1060 / Valor 24839858
NASDAQ (2024-09-18)
USD 64.45+2.40%
Viking Therapeutics Inc
UMushroom community rating:
About company
Viking Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for metabolic and endocrine disorders.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
367%1Y
863%3Y
796%5Y
Performance
118%1Y
96.9%3Y
84.7%5Y
Volatility
6974 M
Market cap (USD)
661,270
Daily traded volume (Shares)
66.05 / 62.68
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
